Adjusted EBITDA of $21 Million for the Third Quarter and $101 Million Year-to-Date
Raises Full-Year 2026 Adjusted EBITDA Guidance Midpoint
Management to Host Conference Call and Webcast November 9, 2026 at 4:30 PM
P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial
P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced the appointment of Dr. Michael Millie as Chief
Raises Full-Year 2026 Adjusted EBITDA Guidance
Management to Host Conference Call and Webcast August 10, 2026 at 4:30 PM ET
P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a
P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial
Raises Full-Year 2026 Adjusted EBITDA Guidance
Management to Host Conference Call and Webcast May 14, 2026 at 4:30 PM ET
P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and
P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first
Providing 2026 Guidance, Indicating a $10 Million Adjusted EBITDA Midpoint
Management to Host Conference Call and Webcast March 26, 2026 at 4:30 PM ET
P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a
P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for
New Partnership Strengthens Value-Based Care Platform for Primary Care Providers
P3 Health Partners ("P3") (NASDAQ:PIII) and Commonwealth Primary Care ACO (Commonwealth) recently announced the formation of a Joint
P3 Reports Continued Operational Progress and Expansion of Care Enablement Model in a Transitional Year
$120 to $170 Million EBITDA Expansion Opportunity Strengthens Path to Meaningful Profitability
Management to
P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for third
P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming Jefferies Healthcare Services
GREENWOOD VILLAGE, Colo., Aug. 25, 2025 /PRNewswire/ -- Catalyst Solutions is thrilled to announce the successful go-live of the Professional Health Partners Services (P3) Implementation, which officially launched in May
Core Business Demonstrates Strength with Flat Medical Cost Trends Despite Industry Inflation
$120-$170 Million in Additional EBITDA Opportunities Identified for 2026
Adjusted Full Year Guidance Reflects Prior Period
